nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP2E1—lung cancer	0.427	1	CbGaD
Aminophylline—CYP2E1—Etoposide—lung cancer	0.0269	0.128	CbGbCtD
Aminophylline—CYP1A2—Erlotinib—lung cancer	0.0215	0.102	CbGbCtD
Aminophylline—CYP3A4—Topotecan—lung cancer	0.0208	0.0989	CbGbCtD
Aminophylline—CYP3A4—Gefitinib—lung cancer	0.0191	0.0905	CbGbCtD
Aminophylline—CYP3A4—Teniposide—lung cancer	0.0185	0.0877	CbGbCtD
Aminophylline—CYP1A2—Etoposide—lung cancer	0.0156	0.0738	CbGbCtD
Aminophylline—CYP3A4—Vinorelbine—lung cancer	0.0147	0.0697	CbGbCtD
Aminophylline—CYP3A4—Crizotinib—lung cancer	0.0117	0.0555	CbGbCtD
Aminophylline—CYP3A4—Erlotinib—lung cancer	0.0113	0.0535	CbGbCtD
Aminophylline—CYP3A4—Paclitaxel—lung cancer	0.0103	0.049	CbGbCtD
Aminophylline—CYP3A4—Irinotecan—lung cancer	0.0102	0.0483	CbGbCtD
Aminophylline—CYP3A4—Vinblastine—lung cancer	0.00905	0.0429	CbGbCtD
Aminophylline—CYP3A4—Etoposide—lung cancer	0.00815	0.0387	CbGbCtD
Aminophylline—CYP3A4—Docetaxel—lung cancer	0.00746	0.0354	CbGbCtD
Aminophylline—CYP3A4—Doxorubicin—lung cancer	0.00556	0.0264	CbGbCtD
Aminophylline—PDE4A—mammary gland—lung cancer	0.00336	0.116	CbGeAlD
Aminophylline—HDAC2—mammary gland—lung cancer	0.00268	0.0927	CbGeAlD
Aminophylline—ADORA2B—bronchus—lung cancer	0.00207	0.0716	CbGeAlD
Aminophylline—ADORA2B—trachea—lung cancer	0.00186	0.0643	CbGeAlD
Aminophylline—HDAC2—respiratory system—lung cancer	0.00178	0.0618	CbGeAlD
Aminophylline—HDAC2—Topotecan—Irinotecan—lung cancer	0.00167	0.284	CbGdCrCtD
Aminophylline—HDAC2—epithelium—lung cancer	0.00149	0.0516	CbGeAlD
Aminophylline—HDAC2—bronchus—lung cancer	0.00147	0.0508	CbGeAlD
Aminophylline—ADORA2B—lung—lung cancer	0.00134	0.0462	CbGeAlD
Aminophylline—PDE3A—cardiac atrium—lung cancer	0.00129	0.0445	CbGeAlD
Aminophylline—ADORA1—cardiac atrium—lung cancer	0.00125	0.0434	CbGeAlD
Aminophylline—PDE4A—lung—lung cancer	0.00119	0.0412	CbGeAlD
Aminophylline—HDAC2—Methotrexate—Pemetrexed—lung cancer	0.00119	0.202	CbGdCrCtD
Aminophylline—HDAC2—Afatinib—Gefitinib—lung cancer	0.00115	0.195	CbGdCrCtD
Aminophylline—HDAC2—Gefitinib—Erlotinib—lung cancer	0.00112	0.191	CbGdCrCtD
Aminophylline—Theophylline—CYP2E1—lung cancer	0.00112	0.503	CrCbGaD
Aminophylline—Theophylline—CYP1A1—lung cancer	0.0011	0.497	CrCbGaD
Aminophylline—HDAC2—bone marrow—lung cancer	0.00105	0.0362	CbGeAlD
Aminophylline—PDE3A—lung—lung cancer	0.000984	0.0341	CbGeAlD
Aminophylline—ADORA1—lung—lung cancer	0.000959	0.0332	CbGeAlD
Aminophylline—HDAC2—lung—lung cancer	0.000947	0.0328	CbGeAlD
Aminophylline—CYP1A2—respiratory system—lung cancer	0.000821	0.0284	CbGeAlD
Aminophylline—PDE4A—lymph node—lung cancer	0.000814	0.0282	CbGeAlD
Aminophylline—HDAC2—Teniposide—Etoposide—lung cancer	0.000752	0.128	CbGdCrCtD
Aminophylline—CYP2E1—respiratory system—lung cancer	0.000738	0.0256	CbGeAlD
Aminophylline—PDE3A—lymph node—lung cancer	0.000673	0.0233	CbGeAlD
Aminophylline—ADORA1—lymph node—lung cancer	0.000656	0.0227	CbGeAlD
Aminophylline—HDAC2—lymph node—lung cancer	0.000648	0.0224	CbGeAlD
Aminophylline—CYP1A2—lung—lung cancer	0.000436	0.0151	CbGeAlD
Aminophylline—CYP2E1—lung—lung cancer	0.000392	0.0136	CbGeAlD
Aminophylline—Skin exfoliation—Doxorubicin—lung cancer	0.000286	0.00158	CcSEcCtD
Aminophylline—Abdominal pain—Vinblastine—lung cancer	0.000286	0.00157	CcSEcCtD
Aminophylline—Gastrointestinal pain—Erlotinib—lung cancer	0.000284	0.00157	CcSEcCtD
Aminophylline—Arrhythmia—Cisplatin—lung cancer	0.000283	0.00156	CcSEcCtD
Aminophylline—Nausea—Teniposide—lung cancer	0.000281	0.00155	CcSEcCtD
Aminophylline—Hypotension—Vinorelbine—lung cancer	0.000281	0.00155	CcSEcCtD
Aminophylline—Alopecia—Cisplatin—lung cancer	0.00028	0.00154	CcSEcCtD
Aminophylline—Urticaria—Topotecan—lung cancer	0.000279	0.00154	CcSEcCtD
Aminophylline—Abdominal pain—Topotecan—lung cancer	0.000278	0.00153	CcSEcCtD
Aminophylline—Body temperature increased—Topotecan—lung cancer	0.000278	0.00153	CcSEcCtD
Aminophylline—Abdominal pain—Erlotinib—lung cancer	0.000275	0.00151	CcSEcCtD
Aminophylline—Body temperature increased—Erlotinib—lung cancer	0.000275	0.00151	CcSEcCtD
Aminophylline—Coma—Doxorubicin—lung cancer	0.000274	0.00151	CcSEcCtD
Aminophylline—Flushing—Etoposide—lung cancer	0.000269	0.00148	CcSEcCtD
Aminophylline—Hypersensitivity—Vinblastine—lung cancer	0.000266	0.00147	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Methotrexate—lung cancer	0.000266	0.00147	CcSEcCtD
Aminophylline—Flushing—Paclitaxel—lung cancer	0.000264	0.00145	CcSEcCtD
Aminophylline—Decreased appetite—Vinorelbine—lung cancer	0.000261	0.00144	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Methotrexate—lung cancer	0.00026	0.00143	CcSEcCtD
Aminophylline—Hypersensitivity—Topotecan—lung cancer	0.000259	0.00143	CcSEcCtD
Aminophylline—Tremor—Cisplatin—lung cancer	0.000258	0.00142	CcSEcCtD
Aminophylline—Alopecia—Etoposide—lung cancer	0.000256	0.00141	CcSEcCtD
Aminophylline—Arrhythmia—Paclitaxel—lung cancer	0.000254	0.0014	CcSEcCtD
Aminophylline—Phlebitis—Doxorubicin—lung cancer	0.000252	0.00139	CcSEcCtD
Aminophylline—Alopecia—Paclitaxel—lung cancer	0.000251	0.00139	CcSEcCtD
Aminophylline—Pruritus—Topotecan—lung cancer	0.000249	0.00137	CcSEcCtD
Aminophylline—Anaphylactic shock—Irinotecan—lung cancer	0.000248	0.00137	CcSEcCtD
Aminophylline—Diarrhoea—Vinblastine—lung cancer	0.000247	0.00136	CcSEcCtD
Aminophylline—Infection—Irinotecan—lung cancer	0.000246	0.00136	CcSEcCtD
Aminophylline—Pruritus—Erlotinib—lung cancer	0.000246	0.00135	CcSEcCtD
Aminophylline—Gastrointestinal pain—Vinorelbine—lung cancer	0.000246	0.00135	CcSEcCtD
Aminophylline—Shock—Irinotecan—lung cancer	0.000244	0.00134	CcSEcCtD
Aminophylline—Nervous system disorder—Irinotecan—lung cancer	0.000243	0.00134	CcSEcCtD
Aminophylline—Tension—Paclitaxel—lung cancer	0.000243	0.00134	CcSEcCtD
Aminophylline—Anaphylactic shock—Gemcitabine—lung cancer	0.000241	0.00133	CcSEcCtD
Aminophylline—Nervousness—Paclitaxel—lung cancer	0.000241	0.00133	CcSEcCtD
Aminophylline—Diarrhoea—Topotecan—lung cancer	0.00024	0.00132	CcSEcCtD
Aminophylline—Infection—Gemcitabine—lung cancer	0.00024	0.00132	CcSEcCtD
Aminophylline—Irritability—Methotrexate—lung cancer	0.00024	0.00132	CcSEcCtD
Aminophylline—Dizziness—Vinblastine—lung cancer	0.000239	0.00132	CcSEcCtD
Aminophylline—Convulsion—Cisplatin—lung cancer	0.000239	0.00132	CcSEcCtD
Aminophylline—Urticaria—Vinorelbine—lung cancer	0.000239	0.00132	CcSEcCtD
Aminophylline—Diarrhoea—Erlotinib—lung cancer	0.000238	0.00131	CcSEcCtD
Aminophylline—Body temperature increased—Vinorelbine—lung cancer	0.000238	0.00131	CcSEcCtD
Aminophylline—Abdominal pain—Vinorelbine—lung cancer	0.000238	0.00131	CcSEcCtD
Aminophylline—Nervous system disorder—Gemcitabine—lung cancer	0.000237	0.0013	CcSEcCtD
Aminophylline—Anorexia—Irinotecan—lung cancer	0.000236	0.0013	CcSEcCtD
Aminophylline—Anxiety—Cisplatin—lung cancer	0.000234	0.00129	CcSEcCtD
Aminophylline—Dizziness—Topotecan—lung cancer	0.000232	0.00128	CcSEcCtD
Aminophylline—Tremor—Paclitaxel—lung cancer	0.000232	0.00128	CcSEcCtD
Aminophylline—Hypotension—Irinotecan—lung cancer	0.000232	0.00128	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000231	0.00127	CcSEcCtD
Aminophylline—Anorexia—Gemcitabine—lung cancer	0.00023	0.00127	CcSEcCtD
Aminophylline—Vomiting—Vinblastine—lung cancer	0.00023	0.00127	CcSEcCtD
Aminophylline—Dizziness—Erlotinib—lung cancer	0.00023	0.00127	CcSEcCtD
Aminophylline—Agitation—Paclitaxel—lung cancer	0.000228	0.00125	CcSEcCtD
Aminophylline—Headache—Vinblastine—lung cancer	0.000227	0.00125	CcSEcCtD
Aminophylline—Hypotension—Gemcitabine—lung cancer	0.000226	0.00124	CcSEcCtD
Aminophylline—Anaphylactic shock—Cisplatin—lung cancer	0.000225	0.00124	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000225	0.00124	CcSEcCtD
Aminophylline—Insomnia—Irinotecan—lung cancer	0.000224	0.00123	CcSEcCtD
Aminophylline—Flushing—Docetaxel—lung cancer	0.000224	0.00123	CcSEcCtD
Aminophylline—Infection—Cisplatin—lung cancer	0.000224	0.00123	CcSEcCtD
Aminophylline—Vomiting—Topotecan—lung cancer	0.000223	0.00123	CcSEcCtD
Aminophylline—Rash—Topotecan—lung cancer	0.000221	0.00122	CcSEcCtD
Aminophylline—Hypersensitivity—Vinorelbine—lung cancer	0.000221	0.00122	CcSEcCtD
Aminophylline—Dermatitis—Topotecan—lung cancer	0.000221	0.00122	CcSEcCtD
Aminophylline—Vomiting—Erlotinib—lung cancer	0.000221	0.00122	CcSEcCtD
Aminophylline—Nervous system disorder—Cisplatin—lung cancer	0.000221	0.00122	CcSEcCtD
Aminophylline—Headache—Topotecan—lung cancer	0.00022	0.00121	CcSEcCtD
Aminophylline—Tachycardia—Cisplatin—lung cancer	0.00022	0.00121	CcSEcCtD
Aminophylline—Rash—Erlotinib—lung cancer	0.000219	0.00121	CcSEcCtD
Aminophylline—Dermatitis—Erlotinib—lung cancer	0.000219	0.00121	CcSEcCtD
Aminophylline—Palpitations—Paclitaxel—lung cancer	0.000219	0.00121	CcSEcCtD
Aminophylline—Convulsion—Etoposide—lung cancer	0.000219	0.00121	CcSEcCtD
Aminophylline—Insomnia—Gemcitabine—lung cancer	0.000218	0.0012	CcSEcCtD
Aminophylline—Dyspepsia—Irinotecan—lung cancer	0.000218	0.0012	CcSEcCtD
Aminophylline—Headache—Erlotinib—lung cancer	0.000218	0.0012	CcSEcCtD
Aminophylline—Decreased appetite—Irinotecan—lung cancer	0.000215	0.00119	CcSEcCtD
Aminophylline—Arrhythmia—Docetaxel—lung cancer	0.000215	0.00119	CcSEcCtD
Aminophylline—Nausea—Vinblastine—lung cancer	0.000215	0.00118	CcSEcCtD
Aminophylline—Convulsion—Paclitaxel—lung cancer	0.000215	0.00118	CcSEcCtD
Aminophylline—Anorexia—Cisplatin—lung cancer	0.000214	0.00118	CcSEcCtD
Aminophylline—Alopecia—Docetaxel—lung cancer	0.000213	0.00117	CcSEcCtD
Aminophylline—Pruritus—Vinorelbine—lung cancer	0.000213	0.00117	CcSEcCtD
Aminophylline—Hypotension—Cisplatin—lung cancer	0.00021	0.00116	CcSEcCtD
Aminophylline—Anxiety—Paclitaxel—lung cancer	0.00021	0.00116	CcSEcCtD
Aminophylline—Decreased appetite—Gemcitabine—lung cancer	0.00021	0.00116	CcSEcCtD
Aminophylline—Nausea—Topotecan—lung cancer	0.000209	0.00115	CcSEcCtD
Aminophylline—Nausea—Erlotinib—lung cancer	0.000206	0.00114	CcSEcCtD
Aminophylline—Anaphylactic shock—Etoposide—lung cancer	0.000206	0.00114	CcSEcCtD
Aminophylline—Diarrhoea—Vinorelbine—lung cancer	0.000206	0.00113	CcSEcCtD
Aminophylline—Infection—Etoposide—lung cancer	0.000205	0.00113	CcSEcCtD
Aminophylline—Gastrointestinal pain—Irinotecan—lung cancer	0.000203	0.00112	CcSEcCtD
Aminophylline—Anaphylactic shock—Paclitaxel—lung cancer	0.000202	0.00111	CcSEcCtD
Aminophylline—Tachycardia—Etoposide—lung cancer	0.000201	0.00111	CcSEcCtD
Aminophylline—Infection—Paclitaxel—lung cancer	0.000201	0.00111	CcSEcCtD
Aminophylline—Shock—Paclitaxel—lung cancer	0.000199	0.0011	CcSEcCtD
Aminophylline—Dizziness—Vinorelbine—lung cancer	0.000199	0.00109	CcSEcCtD
Aminophylline—Abdominal pain upper—Doxorubicin—lung cancer	0.000199	0.00109	CcSEcCtD
Aminophylline—Nervous system disorder—Paclitaxel—lung cancer	0.000198	0.00109	CcSEcCtD
Aminophylline—Hypokalaemia—Doxorubicin—lung cancer	0.000198	0.00109	CcSEcCtD
Aminophylline—Tachycardia—Paclitaxel—lung cancer	0.000197	0.00109	CcSEcCtD
Aminophylline—Anorexia—Etoposide—lung cancer	0.000196	0.00108	CcSEcCtD
Aminophylline—Abdominal pain—Irinotecan—lung cancer	0.000196	0.00108	CcSEcCtD
Aminophylline—Body temperature increased—Irinotecan—lung cancer	0.000196	0.00108	CcSEcCtD
Aminophylline—Decreased appetite—Cisplatin—lung cancer	0.000196	0.00108	CcSEcCtD
Aminophylline—Anorexia—Paclitaxel—lung cancer	0.000193	0.00106	CcSEcCtD
Aminophylline—Hypotension—Etoposide—lung cancer	0.000193	0.00106	CcSEcCtD
Aminophylline—Vomiting—Vinorelbine—lung cancer	0.000191	0.00105	CcSEcCtD
Aminophylline—Body temperature increased—Gemcitabine—lung cancer	0.000191	0.00105	CcSEcCtD
Aminophylline—Rash—Vinorelbine—lung cancer	0.000189	0.00104	CcSEcCtD
Aminophylline—Dermatitis—Vinorelbine—lung cancer	0.000189	0.00104	CcSEcCtD
Aminophylline—Hypotension—Paclitaxel—lung cancer	0.000189	0.00104	CcSEcCtD
Aminophylline—Headache—Vinorelbine—lung cancer	0.000188	0.00104	CcSEcCtD
Aminophylline—Palpitations—Docetaxel—lung cancer	0.000185	0.00102	CcSEcCtD
Aminophylline—Haematuria—Methotrexate—lung cancer	0.000185	0.00102	CcSEcCtD
Aminophylline—Insomnia—Paclitaxel—lung cancer	0.000183	0.00101	CcSEcCtD
Aminophylline—Hypersensitivity—Irinotecan—lung cancer	0.000183	0.00101	CcSEcCtD
Aminophylline—Convulsion—Docetaxel—lung cancer	0.000182	0.001	CcSEcCtD
Aminophylline—Decreased appetite—Etoposide—lung cancer	0.000179	0.000987	CcSEcCtD
Aminophylline—Nausea—Vinorelbine—lung cancer	0.000178	0.000983	CcSEcCtD
Aminophylline—Dyspepsia—Paclitaxel—lung cancer	0.000178	0.00098	CcSEcCtD
Aminophylline—Body temperature increased—Cisplatin—lung cancer	0.000178	0.00098	CcSEcCtD
Aminophylline—Decreased appetite—Paclitaxel—lung cancer	0.000176	0.000968	CcSEcCtD
Aminophylline—Anaphylactic shock—Docetaxel—lung cancer	0.000171	0.000944	CcSEcCtD
Aminophylline—Pruritus—Gemcitabine—lung cancer	0.000171	0.000941	CcSEcCtD
Aminophylline—Infection—Docetaxel—lung cancer	0.00017	0.000938	CcSEcCtD
Aminophylline—Hyperglycaemia—Doxorubicin—lung cancer	0.00017	0.000934	CcSEcCtD
Aminophylline—Diarrhoea—Irinotecan—lung cancer	0.00017	0.000934	CcSEcCtD
Aminophylline—Gastrointestinal pain—Etoposide—lung cancer	0.000169	0.000929	CcSEcCtD
Aminophylline—Shock—Docetaxel—lung cancer	0.000169	0.000929	CcSEcCtD
Aminophylline—Nervous system disorder—Docetaxel—lung cancer	0.000168	0.000926	CcSEcCtD
Aminophylline—Tachycardia—Docetaxel—lung cancer	0.000167	0.000921	CcSEcCtD
Aminophylline—Hypersensitivity—Cisplatin—lung cancer	0.000166	0.000913	CcSEcCtD
Aminophylline—Gastrointestinal pain—Paclitaxel—lung cancer	0.000165	0.000911	CcSEcCtD
Aminophylline—Diarrhoea—Gemcitabine—lung cancer	0.000165	0.00091	CcSEcCtD
Aminophylline—Dizziness—Irinotecan—lung cancer	0.000164	0.000903	CcSEcCtD
Aminophylline—Urticaria—Etoposide—lung cancer	0.000164	0.000902	CcSEcCtD
Aminophylline—Anorexia—Docetaxel—lung cancer	0.000163	0.0009	CcSEcCtD
Aminophylline—Abdominal pain—Etoposide—lung cancer	0.000163	0.000898	CcSEcCtD
Aminophylline—Body temperature increased—Etoposide—lung cancer	0.000163	0.000898	CcSEcCtD
Aminophylline—Urticaria—Paclitaxel—lung cancer	0.000161	0.000885	CcSEcCtD
Aminophylline—Hypotension—Docetaxel—lung cancer	0.00016	0.000882	CcSEcCtD
Aminophylline—Haematuria—Doxorubicin—lung cancer	0.00016	0.000881	CcSEcCtD
Aminophylline—Abdominal pain—Paclitaxel—lung cancer	0.00016	0.00088	CcSEcCtD
Aminophylline—Body temperature increased—Paclitaxel—lung cancer	0.00016	0.00088	CcSEcCtD
Aminophylline—Vomiting—Irinotecan—lung cancer	0.000158	0.000868	CcSEcCtD
Aminophylline—Rash—Irinotecan—lung cancer	0.000156	0.000861	CcSEcCtD
Aminophylline—Dermatitis—Irinotecan—lung cancer	0.000156	0.00086	CcSEcCtD
Aminophylline—Headache—Irinotecan—lung cancer	0.000155	0.000855	CcSEcCtD
Aminophylline—Insomnia—Docetaxel—lung cancer	0.000155	0.000854	CcSEcCtD
Aminophylline—Diarrhoea—Cisplatin—lung cancer	0.000154	0.000848	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—lung cancer	0.000154	0.000846	CcSEcCtD
Aminophylline—Vomiting—Gemcitabine—lung cancer	0.000153	0.000846	CcSEcCtD
Aminophylline—Rash—Gemcitabine—lung cancer	0.000152	0.000839	CcSEcCtD
Aminophylline—Dermatitis—Gemcitabine—lung cancer	0.000152	0.000838	CcSEcCtD
Aminophylline—Hypersensitivity—Etoposide—lung cancer	0.000152	0.000837	CcSEcCtD
Aminophylline—Headache—Gemcitabine—lung cancer	0.000151	0.000833	CcSEcCtD
Aminophylline—Dyspepsia—Docetaxel—lung cancer	0.000151	0.000831	CcSEcCtD
Aminophylline—Decreased appetite—Docetaxel—lung cancer	0.000149	0.000821	CcSEcCtD
Aminophylline—Hypersensitivity—Paclitaxel—lung cancer	0.000149	0.00082	CcSEcCtD
Aminophylline—Nausea—Irinotecan—lung cancer	0.000147	0.000811	CcSEcCtD
Aminophylline—Pruritus—Etoposide—lung cancer	0.000146	0.000804	CcSEcCtD
Aminophylline—Nausea—Gemcitabine—lung cancer	0.000143	0.00079	CcSEcCtD
Aminophylline—Vomiting—Cisplatin—lung cancer	0.000143	0.000788	CcSEcCtD
Aminophylline—Pruritus—Paclitaxel—lung cancer	0.000143	0.000788	CcSEcCtD
Aminophylline—Rash—Cisplatin—lung cancer	0.000142	0.000782	CcSEcCtD
Aminophylline—Dermatitis—Cisplatin—lung cancer	0.000142	0.000781	CcSEcCtD
Aminophylline—Diarrhoea—Etoposide—lung cancer	0.000141	0.000777	CcSEcCtD
Aminophylline—Gastrointestinal pain—Docetaxel—lung cancer	0.00014	0.000772	CcSEcCtD
Aminophylline—Flushing—Doxorubicin—lung cancer	0.00014	0.00077	CcSEcCtD
Aminophylline—Diarrhoea—Paclitaxel—lung cancer	0.000138	0.000762	CcSEcCtD
Aminophylline—Dizziness—Etoposide—lung cancer	0.000136	0.000751	CcSEcCtD
Aminophylline—Body temperature increased—Docetaxel—lung cancer	0.000135	0.000746	CcSEcCtD
Aminophylline—Abdominal pain—Docetaxel—lung cancer	0.000135	0.000746	CcSEcCtD
Aminophylline—Arrhythmia—Doxorubicin—lung cancer	0.000134	0.000741	CcSEcCtD
Aminophylline—Dizziness—Paclitaxel—lung cancer	0.000134	0.000736	CcSEcCtD
Aminophylline—Nausea—Cisplatin—lung cancer	0.000134	0.000736	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—lung cancer	0.000133	0.000733	CcSEcCtD
Aminophylline—Convulsion—Methotrexate—lung cancer	0.000131	0.000722	CcSEcCtD
Aminophylline—Vomiting—Etoposide—lung cancer	0.000131	0.000722	CcSEcCtD
Aminophylline—Rash—Etoposide—lung cancer	0.00013	0.000716	CcSEcCtD
Aminophylline—Dermatitis—Etoposide—lung cancer	0.00013	0.000715	CcSEcCtD
Aminophylline—Headache—Etoposide—lung cancer	0.000129	0.000712	CcSEcCtD
Aminophylline—Tension—Doxorubicin—lung cancer	0.000129	0.000708	CcSEcCtD
Aminophylline—Vomiting—Paclitaxel—lung cancer	0.000128	0.000708	CcSEcCtD
Aminophylline—Rash—Paclitaxel—lung cancer	0.000127	0.000702	CcSEcCtD
Aminophylline—Dermatitis—Paclitaxel—lung cancer	0.000127	0.000701	CcSEcCtD
Aminophylline—Nervousness—Doxorubicin—lung cancer	0.000127	0.000701	CcSEcCtD
Aminophylline—Headache—Paclitaxel—lung cancer	0.000127	0.000698	CcSEcCtD
Aminophylline—Hypersensitivity—Docetaxel—lung cancer	0.000126	0.000695	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—lung cancer	0.000123	0.00068	CcSEcCtD
Aminophylline—Infection—Methotrexate—lung cancer	0.000123	0.000676	CcSEcCtD
Aminophylline—Nausea—Etoposide—lung cancer	0.000122	0.000675	CcSEcCtD
Aminophylline—Pruritus—Docetaxel—lung cancer	0.000121	0.000668	CcSEcCtD
Aminophylline—Nervous system disorder—Methotrexate—lung cancer	0.000121	0.000667	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—lung cancer	0.00012	0.000663	CcSEcCtD
Aminophylline—Nausea—Paclitaxel—lung cancer	0.00012	0.000661	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—lung cancer	0.000118	0.000648	CcSEcCtD
Aminophylline—Diarrhoea—Docetaxel—lung cancer	0.000117	0.000646	CcSEcCtD
Aminophylline—Palpitations—Doxorubicin—lung cancer	0.000116	0.000638	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—lung cancer	0.000115	0.000636	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—lung cancer	0.000113	0.000625	CcSEcCtD
Aminophylline—Dizziness—Docetaxel—lung cancer	0.000113	0.000624	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—lung cancer	0.000112	0.000615	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—lung cancer	0.000111	0.000612	CcSEcCtD
Aminophylline—Vomiting—Docetaxel—lung cancer	0.000109	0.0006	CcSEcCtD
Aminophylline—Dyspepsia—Methotrexate—lung cancer	0.000109	0.000599	CcSEcCtD
Aminophylline—Rash—Docetaxel—lung cancer	0.000108	0.000595	CcSEcCtD
Aminophylline—Dermatitis—Docetaxel—lung cancer	0.000108	0.000595	CcSEcCtD
Aminophylline—Decreased appetite—Methotrexate—lung cancer	0.000107	0.000591	CcSEcCtD
Aminophylline—Headache—Docetaxel—lung cancer	0.000107	0.000591	CcSEcCtD
Aminophylline—Anaphylactic shock—Doxorubicin—lung cancer	0.000107	0.000589	CcSEcCtD
Aminophylline—Infection—Doxorubicin—lung cancer	0.000106	0.000585	CcSEcCtD
Aminophylline—Shock—Doxorubicin—lung cancer	0.000105	0.00058	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—lung cancer	0.000105	0.000578	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—lung cancer	0.000104	0.000575	CcSEcCtD
Aminophylline—Anorexia—Doxorubicin—lung cancer	0.000102	0.000562	CcSEcCtD
Aminophylline—Nausea—Docetaxel—lung cancer	0.000102	0.000561	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—lung cancer	0.000101	0.000556	CcSEcCtD
Aminophylline—Hypotension—Doxorubicin—lung cancer	9.99e-05	0.00055	CcSEcCtD
Aminophylline—Urticaria—Methotrexate—lung cancer	9.81e-05	0.00054	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—lung cancer	9.76e-05	0.000538	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—lung cancer	9.76e-05	0.000538	CcSEcCtD
Aminophylline—Insomnia—Doxorubicin—lung cancer	9.67e-05	0.000533	CcSEcCtD
Aminophylline—Dyspepsia—Doxorubicin—lung cancer	9.41e-05	0.000519	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—lung cancer	9.29e-05	0.000512	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—lung cancer	9.1e-05	0.000501	CcSEcCtD
Aminophylline—Gastrointestinal pain—Doxorubicin—lung cancer	8.74e-05	0.000482	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—lung cancer	8.74e-05	0.000481	CcSEcCtD
Aminophylline—Urticaria—Doxorubicin—lung cancer	8.49e-05	0.000468	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—lung cancer	8.45e-05	0.000466	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—lung cancer	8.45e-05	0.000466	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—lung cancer	8.45e-05	0.000465	CcSEcCtD
Aminophylline—Dizziness—Methotrexate—lung cancer	8.16e-05	0.00045	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—lung cancer	7.88e-05	0.000434	CcSEcCtD
Aminophylline—Vomiting—Methotrexate—lung cancer	7.85e-05	0.000433	CcSEcCtD
Aminophylline—Rash—Methotrexate—lung cancer	7.78e-05	0.000429	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—lung cancer	7.78e-05	0.000429	CcSEcCtD
Aminophylline—Headache—Methotrexate—lung cancer	7.73e-05	0.000426	CcSEcCtD
Aminophylline—Pruritus—Doxorubicin—lung cancer	7.56e-05	0.000417	CcSEcCtD
Aminophylline—Nausea—Methotrexate—lung cancer	7.33e-05	0.000404	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—lung cancer	7.31e-05	0.000403	CcSEcCtD
Aminophylline—Dizziness—Doxorubicin—lung cancer	7.07e-05	0.00039	CcSEcCtD
Aminophylline—Vomiting—Doxorubicin—lung cancer	6.8e-05	0.000375	CcSEcCtD
Aminophylline—Rash—Doxorubicin—lung cancer	6.74e-05	0.000371	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—lung cancer	6.73e-05	0.000371	CcSEcCtD
Aminophylline—Headache—Doxorubicin—lung cancer	6.7e-05	0.000369	CcSEcCtD
Aminophylline—Nausea—Doxorubicin—lung cancer	6.35e-05	0.00035	CcSEcCtD
Aminophylline—HDAC2—Disease—NRAS—lung cancer	1.22e-05	8.43e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL6—lung cancer	1.21e-05	8.43e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCC3—lung cancer	1.21e-05	8.41e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—STAT3—lung cancer	1.21e-05	8.38e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SDC4—lung cancer	1.21e-05	8.38e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—NRAS—lung cancer	1.21e-05	8.36e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MMP9—lung cancer	1.2e-05	8.33e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—AKT1—lung cancer	1.2e-05	8.3e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CDKN1A—lung cancer	1.2e-05	8.3e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTEN—lung cancer	1.19e-05	8.28e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCND1—lung cancer	1.19e-05	8.26e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—JUN—lung cancer	1.19e-05	8.24e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAP2K1—lung cancer	1.19e-05	8.22e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CD—lung cancer	1.18e-05	8.17e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AKR1C1—lung cancer	1.17e-05	8.14e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—STK11—lung cancer	1.17e-05	8.13e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EP300—lung cancer	1.17e-05	8.12e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—PIK3CA—lung cancer	1.17e-05	8.09e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—AKT1—lung cancer	1.16e-05	8.08e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MAPK3—lung cancer	1.16e-05	8.07e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MMP9—lung cancer	1.16e-05	8.02e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MAPK3—lung cancer	1.15e-05	8.01e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—KRAS—lung cancer	1.15e-05	8e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CDKN1A—lung cancer	1.15e-05	7.99e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTEN—lung cancer	1.15e-05	7.97e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—UGT1A1—lung cancer	1.14e-05	7.91e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EP300—lung cancer	1.14e-05	7.89e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SRC—lung cancer	1.14e-05	7.89e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MDM2—lung cancer	1.13e-05	7.87e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MYC—lung cancer	1.13e-05	7.85e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—RAF1—lung cancer	1.13e-05	7.84e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MYC—lung cancer	1.12e-05	7.79e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—AKT1—lung cancer	1.12e-05	7.77e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ERBB2—lung cancer	1.12e-05	7.76e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—lung cancer	1.11e-05	7.69e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EGFR—lung cancer	1.11e-05	7.68e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SRC—lung cancer	1.11e-05	7.68e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CB—lung cancer	1.1e-05	7.66e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MTOR—lung cancer	1.1e-05	7.66e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—RRM1—lung cancer	1.1e-05	7.63e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTA3—lung cancer	1.1e-05	7.63e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GNG11—lung cancer	1.1e-05	7.62e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EGFR—lung cancer	1.1e-05	7.62e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—STAT3—lung cancer	1.1e-05	7.61e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EP300—lung cancer	1.1e-05	7.6e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—NRAS—lung cancer	1.09e-05	7.59e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.09e-05	7.59e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTP1—lung cancer	1.08e-05	7.52e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—lung cancer	1.08e-05	7.48e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—STAT3—lung cancer	1.07e-05	7.4e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SRC—lung cancer	1.07e-05	7.39e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—NRAS—lung cancer	1.06e-05	7.39e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CXCL8—lung cancer	1.06e-05	7.36e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PIK3CA—lung cancer	1.06e-05	7.35e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MDM2—lung cancer	1.05e-05	7.32e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CAT—lung cancer	1.05e-05	7.32e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RAF1—lung cancer	1.05e-05	7.29e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MAPK3—lung cancer	1.05e-05	7.27e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALDOA—lung cancer	1.05e-05	7.26e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KRAS—lung cancer	1.05e-05	7.26e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ERBB2—lung cancer	1.04e-05	7.21e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—lung cancer	1.04e-05	7.2e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KRAS—lung cancer	1.04e-05	7.2e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—B4GALT5—lung cancer	1.03e-05	7.18e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—STAT3—lung cancer	1.03e-05	7.13e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CB—lung cancer	1.03e-05	7.12e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MTOR—lung cancer	1.03e-05	7.12e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ABCB1—lung cancer	1.03e-05	7.12e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—NRAS—lung cancer	1.02e-05	7.11e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MAPK3—lung cancer	1.02e-05	7.07e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MYC—lung cancer	1.02e-05	7.07e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NCOA3—lung cancer	1.02e-05	7.05e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CASP3—lung cancer	1.02e-05	7.04e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL2—lung cancer	1.01e-05	7.03e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—TYMS—lung cancer	1.01e-05	6.99e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTA4—lung cancer	1.01e-05	6.98e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.98e-06	6.93e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EGFR—lung cancer	9.97e-06	6.92e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTM1—lung cancer	9.96e-06	6.91e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MYC—lung cancer	9.92e-06	6.88e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCND1—lung cancer	9.88e-06	6.86e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ADCY1—lung cancer	9.88e-06	6.86e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCG2—lung cancer	9.88e-06	6.86e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CXCL8—lung cancer	9.86e-06	6.84e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—JUN—lung cancer	9.86e-06	6.84e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MAPK3—lung cancer	9.81e-06	6.81e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTA2—lung cancer	9.81e-06	6.8e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—HRAS—lung cancer	9.8e-06	6.8e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EGFR—lung cancer	9.7e-06	6.73e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO2—lung cancer	9.69e-06	6.72e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HPGDS—lung cancer	9.69e-06	6.72e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PPP2R1B—lung cancer	9.63e-06	6.68e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PIK3CA—lung cancer	9.61e-06	6.67e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MMP9—lung cancer	9.6e-06	6.66e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CDKN1A—lung cancer	9.56e-06	6.63e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MYC—lung cancer	9.55e-06	6.62e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTEN—lung cancer	9.54e-06	6.62e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PIK3CA—lung cancer	9.53e-06	6.61e-05	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—AKT1—lung cancer	9.53e-06	6.61e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.5e-06	6.59e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTA1—lung cancer	9.46e-06	6.56e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP1A1—lung cancer	9.44e-06	6.55e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CASP3—lung cancer	9.44e-06	6.55e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL2—lung cancer	9.43e-06	6.54e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KRAS—lung cancer	9.42e-06	6.53e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTT1—lung cancer	9.4e-06	6.52e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL6—lung cancer	9.38e-06	6.51e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ERCC2—lung cancer	9.36e-06	6.5e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCC3—lung cancer	9.36e-06	6.49e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGFR—lung cancer	9.34e-06	6.48e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GCLC—lung cancer	9.29e-06	6.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP2A6—lung cancer	9.29e-06	6.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.25e-06	6.42e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—lung cancer	9.22e-06	6.4e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCND1—lung cancer	9.19e-06	6.37e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—JUN—lung cancer	9.17e-06	6.36e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KRAS—lung cancer	9.16e-06	6.36e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EP300—lung cancer	9.1e-06	6.31e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AKR1C1—lung cancer	9.06e-06	6.29e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MMP9—lung cancer	8.92e-06	6.19e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—HRAS—lung cancer	8.89e-06	6.17e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CDKN1A—lung cancer	8.89e-06	6.17e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTEN—lung cancer	8.87e-06	6.15e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SRC—lung cancer	8.85e-06	6.14e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KRAS—lung cancer	8.82e-06	6.12e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—HRAS—lung cancer	8.82e-06	6.12e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO1—lung cancer	8.81e-06	6.11e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—UGT1A1—lung cancer	8.8e-06	6.1e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.78e-06	6.09e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.66e-06	6.01e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CA—lung cancer	8.65e-06	6e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—AKT1—lung cancer	8.65e-06	6e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—lung cancer	8.62e-06	5.98e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—STAT3—lung cancer	8.53e-06	5.92e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—NRAS—lung cancer	8.51e-06	5.9e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—IL6—lung cancer	8.51e-06	5.9e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GNG11—lung cancer	8.48e-06	5.88e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EP300—lung cancer	8.46e-06	5.87e-05	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—AKT1—lung cancer	8.46e-06	5.87e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL6—lung cancer	8.44e-06	5.85e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CA—lung cancer	8.42e-06	5.84e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—lung cancer	8.37e-06	5.81e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SRC—lung cancer	8.22e-06	5.71e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MAPK3—lung cancer	8.15e-06	5.65e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—lung cancer	8.14e-06	5.65e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CA—lung cancer	8.1e-06	5.62e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—APOA1—lung cancer	8.1e-06	5.62e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALDOA—lung cancer	8.08e-06	5.6e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—lung cancer	8.01e-06	5.56e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—HRAS—lung cancer	8.01e-06	5.55e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—STAT3—lung cancer	7.93e-06	5.5e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MYC—lung cancer	7.93e-06	5.5e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—NRAS—lung cancer	7.91e-06	5.49e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP2E1—lung cancer	7.9e-06	5.48e-05	CbGpPWpGaD
Aminophylline—HDAC2—Disease—AKT1—lung cancer	7.85e-06	5.45e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NCOA3—lung cancer	7.84e-06	5.44e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—lung cancer	7.84e-06	5.44e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NQO1—lung cancer	7.81e-06	5.42e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—HRAS—lung cancer	7.79e-06	5.4e-05	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—AKT1—lung cancer	7.78e-06	5.4e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGFR—lung cancer	7.75e-06	5.38e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL6—lung cancer	7.66e-06	5.32e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.65e-06	5.31e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ADCY1—lung cancer	7.63e-06	5.29e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCG2—lung cancer	7.63e-06	5.29e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.58e-06	5.26e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAPK3—lung cancer	7.58e-06	5.26e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—HRAS—lung cancer	7.5e-06	5.2e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HPGDS—lung cancer	7.48e-06	5.19e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO2—lung cancer	7.48e-06	5.19e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL6—lung cancer	7.45e-06	5.17e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.43e-06	5.16e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CG—lung cancer	7.4e-06	5.13e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MYC—lung cancer	7.37e-06	5.11e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KRAS—lung cancer	7.32e-06	5.08e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTT1—lung cancer	7.25e-06	5.03e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGFR—lung cancer	7.21e-06	5e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL6—lung cancer	7.18e-06	4.98e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GCLC—lung cancer	7.17e-06	4.97e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP2A6—lung cancer	7.17e-06	4.97e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—AKT1—lung cancer	7.07e-06	4.9e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—STK11—lung cancer	7.04e-06	4.88e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—POMC—lung cancer	7.04e-06	4.88e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—AKT1—lung cancer	6.88e-06	4.77e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CREBBP—lung cancer	6.86e-06	4.76e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KRAS—lung cancer	6.81e-06	4.72e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO1—lung cancer	6.8e-06	4.72e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CA—lung cancer	6.73e-06	4.67e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—AKT1—lung cancer	6.62e-06	4.59e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.61e-06	4.59e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTP1—lung cancer	6.51e-06	4.52e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—lung cancer	6.51e-06	4.52e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CD—lung cancer	6.5e-06	4.51e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ALB—lung cancer	6.42e-06	4.45e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CAT—lung cancer	6.34e-06	4.4e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.3e-06	4.37e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CA—lung cancer	6.26e-06	4.34e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HRAS—lung cancer	6.23e-06	4.32e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCB1—lung cancer	6.17e-06	4.28e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP2E1—lung cancer	6.1e-06	4.23e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—TYMS—lung cancer	6.06e-06	4.2e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—lung cancer	6.05e-06	4.2e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NQO1—lung cancer	6.03e-06	4.18e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTM1—lung cancer	5.99e-06	4.15e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL6—lung cancer	5.96e-06	4.13e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HRAS—lung cancer	5.79e-06	4.02e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP1A1—lung cancer	5.68e-06	3.94e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CB—lung cancer	5.67e-06	3.93e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ERCC2—lung cancer	5.63e-06	3.91e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—lung cancer	5.61e-06	3.9e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL6—lung cancer	5.54e-06	3.84e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—AKT1—lung cancer	5.5e-06	3.81e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—STK11—lung cancer	5.43e-06	3.77e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—AKT1—lung cancer	5.11e-06	3.55e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTP1—lung cancer	5.03e-06	3.49e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTEN—lung cancer	4.9e-06	3.4e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CAT—lung cancer	4.89e-06	3.39e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—APOA1—lung cancer	4.87e-06	3.38e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCB1—lung cancer	4.76e-06	3.3e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—TYMS—lung cancer	4.67e-06	3.24e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—EP300—lung cancer	4.67e-06	3.24e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.66e-06	3.23e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTM1—lung cancer	4.62e-06	3.21e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CG—lung cancer	4.45e-06	3.08e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP1A1—lung cancer	4.38e-06	3.04e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ERCC2—lung cancer	4.34e-06	3.01e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—POMC—lung cancer	4.23e-06	2.94e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CREBBP—lung cancer	4.12e-06	2.86e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CD—lung cancer	3.91e-06	2.71e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALB—lung cancer	3.86e-06	2.68e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APOA1—lung cancer	3.76e-06	2.61e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CA—lung cancer	3.45e-06	2.4e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CG—lung cancer	3.43e-06	2.38e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CB—lung cancer	3.41e-06	2.36e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—lung cancer	3.38e-06	2.34e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—POMC—lung cancer	3.27e-06	2.27e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CREBBP—lung cancer	3.18e-06	2.21e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CD—lung cancer	3.02e-06	2.09e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALB—lung cancer	2.98e-06	2.07e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTEN—lung cancer	2.94e-06	2.04e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—AKT1—lung cancer	2.82e-06	1.96e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—EP300—lung cancer	2.81e-06	1.95e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CB—lung cancer	2.63e-06	1.82e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—lung cancer	2.6e-06	1.81e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTEN—lung cancer	2.27e-06	1.58e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—EP300—lung cancer	2.17e-06	1.5e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CA—lung cancer	2.08e-06	1.44e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—AKT1—lung cancer	1.7e-06	1.18e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CA—lung cancer	1.6e-06	1.11e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—AKT1—lung cancer	1.31e-06	9.08e-06	CbGpPWpGaD
